Clinical Trial

Exploratory Study of Super DC Cell Injection in Preventing Recurrence After Radical Surgery for Tumors

Recruiting Phase 1/2
View on ClinicalTrials.gov →
Summary
The study is a controlled, open-label exploratory clinical trial.
Trial Details
NCT Number NCT07146672
Lead Sponsor Shanghai Cell Therapy Group Co.,Ltd
Conditions Solid Tumor Cancer
Enrollment 12 participants
Start Date 2025-07-31
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-08-28